HC

Hemaxiben Chandreshkumar Patel

Active Director Director DIN 08864271
DIN 08864271 First appointment Sep 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Hemaxiben Chandreshkumar Patel

Data last updated:

Hemaxiben Chandreshkumar Patel is a Director at Devraj Globex Private Limited (since 2020). The company operates in Chemicals.

DIN 08864271
Primary Designation Director
Industry Chemicals
First Appointment 04 Sep 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Devraj Globex Private Limited U24239GJ2020PTC116179
Director04 Sep 20202020Active

Board colleagues of Hemaxiben Chandreshkumar Patel

NameDINCompanyDesignation
Ishan Chandreshbhai Patel08864270Devraj Globex Private LimitedDirector

Directorship timeline

Open interactive timeline →
Devraj Globex Private Limited
Premium access

Shareholding and investment profile for Hemaxiben Chandreshkumar Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hemaxiben Chandreshkumar Patel

Hemaxiben Chandreshkumar Patel currently holds 1 directorship: Devraj Globex Private Limited (Director, since 04 Sep 2020).

Hemaxiben Chandreshkumar Patel was first appointed on 04 Sep 2020 as Director at Devraj Globex Private Limited.

The current boards of Hemaxiben Chandreshkumar Patel's companies include Ishan Chandreshbhai Patel (Devraj Globex Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available